The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

James M. McKenney

Chief Executive Officer

National Clinical Research

Inc., Richmond

VA

[email]@ncrinc.net

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Chief Executive Officer, National Clinical Research, Inc., Richmond, VA. 2012
  • National Clinical Research Inc., 2809 Emerywood Parkway, Suite 140, Richmond, USA. 2003 - 2010
  • National Clinical Research, Richmond, VA 23227, United States. 2002 - 2007
  • Virginia Commonwealth University, Richmond, Virginia, USA. 2001 - 2007
  • Virginia Commonwealth University and National Clinical Research, Richmond, Virginia 23294, USA. 2005 - 2006

References

  1. Combination treatment with atorvastatin plus niacin provides effective control of complex dyslipidemias: a literature review. McKenney, J.M. Postgrad. Med (2012) [Pubmed]
  2. Safety of extended-release niacin/laropiprant in patients with dyslipidemia. McKenney, J., Bays, H., Koren, M., Ballantyne, C.M., Paolini, J.F., Mitchel, Y., Betteridge, A., Kuznetsova, O., Sapre, A., Sisk, C.M., Maccubbin, D. J. Clin. Lipidol (2010) [Pubmed]
  3. Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study). McKenney, J.M., Jones, P.H., Bays, H.E., Knopp, R.H., Kashyap, M.L., Ruoff, G.E., McGovern, M.E. Atherosclerosis (2007) [Pubmed]
  4. Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia. McKenney, J.M., Sica, D. Am. J. Health. Syst. Pharm (2007) [Pubmed]
  5. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia. McKenney, J.M., Sica, D. Pharmacotherapy (2007) [Pubmed]
  6. Will torcetrapib be the next big thing in coronary heart disease risk reduction?. McKenney, J.M., Hoekstra, J.A. Curr. Atheroscler. Rep (2007) [Pubmed]
  7. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. McKenney, J.M., Davidson, M.H., Jacobson, T.A., Guyton, J.R. Am. J. Cardiol. (2006) [Pubmed]
  8. Safety and efficacy of long-term co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia. McKenney, J.M., Farnier, M., Lo, K.W., Bays, H.E., Perevozkaya, I., Carlson, G., Davies, M.J., Mitchel, Y.B., Gumbiner, B. J. Am. Coll. Cardiol. (2006) [Pubmed]
  9. An assessment of statin safety. McKenney, J.M. Am. J. Manag. Care (2006) [Pubmed]
  10. Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels on a background of atorvastatin. McKenney, J.M., Davidson, M.H., Shear, C.L., Revkin, J.H. J. Am. Coll. Cardiol. (2006) [Pubmed]
  11. Efficacy and safety of rosuvastatin in treatment of dyslipidemia. McKenney, J.M. Am. J. Health. Syst. Pharm (2005) [Pubmed]
  12. Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks. McKenney, J.M. Am. J. Cardiol. (2005) [Pubmed]
  13. Safety and efficacy of colesevelam hydrochloride in combination with fenofibrate for the treatment of mixed hyperlipidemia. McKenney, J., Jones, M., Abby, S. Curr. Med. Res. Opin (2005) [Pubmed]
  14. Use of a treatment algorithm to achieve NCEP ATP III goals with atorvastatin. McKenney, J.M., Davidson, M.H., Saponaro, J., Thompson, P.D., Bays, H.E. J. Cardiovasc. Pharmacol. (2005) [Pubmed]
  15. LDL-C goal attainment with ezetimibe plus simvastatin coadministration vs atorvastatin or simvastatin monotherapy in patients at high risk of CHD. McKenney, J., Ballantyne, C.M., Feldman, T.A., Brady, W.E., Shah, A., Davies, M.J., Palmisano, J., Mitchel, Y.B. MedGenMed (2005) [Pubmed]
  16. Optimizing LDL-C lowering with statins. McKenney, J.M. Am. J. Ther (2004) [Pubmed]
  17. New perspectives on the use of niacin in the treatment of lipid disorders. McKenney, J. Arch. Intern. Med. (2004) [Pubmed]
  18. National survey of pharmacists about coronary heart disease, hypercholesterolemia, nonprescription statintherapy, and pharmacists' services. McKenney, J.M., Bradberry, J.C., Talbert, R.L., Cahill, E., Brown, W.V. J. Am. Pharm. Assoc. (2003) (2004) [Pubmed]
  19. The National Lipid Association surveys of consumers, physicians, and pharmacists regarding an over-the-counter statin in the United States: is this a good idea?. McKenney, J.M., Brown, W.V., Cohen, J.D., Cahill, E. Am. J. Cardiol. (2004) [Pubmed]
  20. Pharmacologic characteristics of statins. McKenney, J.M. Clin. Cardiol (2003) [Pubmed]
  21. Niacin for dyslipidemia: considerations in product selection. McKenney, J. Am. J. Health. Syst. Pharm (2003) [Pubmed]
  22. Potential nontraditional applications of statins. McKenney, J.M. Ann. Pharmacother (2003) [Pubmed]
  23. Update on the National Cholesterol Education Program Adult Treatment Panel III guidelines: getting to goal. McKenney, J.M. Pharmacotherapy (2003) [Pubmed]
  24. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial. McKenney, J.M., Jones, P.H., Adamczyk, M.A., Cain, V.A., Bryzinski, B.S., Blasetto, J.W. Curr. Med. Res. Opin (2003) [Pubmed]
  25. New cholesterol guidelines, new treatment challenges. McKenney, J.M. Pharmacotherapy (2002) [Pubmed]
  26. Combination therapy for elevated low-density lipoprotein cholesterol: the key to coronary artery disease risk reduction. McKenney, J. Am. J. Cardiol. (2002) [Pubmed]
  27. Achieving blood lipid goals in patients with coronary artery disease. McKenney, J.M. Am. J. Health. Syst. Pharm (2001) [Pubmed]
  28. Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemia. McKenney, J.M., McCormick, L.S., Schaefer, E.J., Black, D.M., Watkins, M.L. Am. J. Cardiol. (2001) [Pubmed]
  29. New guidelines for managing hypercholesterolemia. McKenney, J.M. J. Am. Pharm. Assoc. (Wash) (2001) [Pubmed]
  30. Pharmacotherapy of dyslipidemia. McKenney, J.M. Cardiovasc. Drugs. Ther (2001) [Pubmed]
 
WikiGenes - Universities